R

ReviR Therapeutics

25 employees

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Alternative Medicine
Genetics

Date founded

2021

Funding rounds raised

Total raised

$20M

from 4 investors over 4 rounds

R

ReviR Therapeutics raised $20M on January 17, 2022

Investors: Sky9 Capital, CDH Investments, Morningside Venture Capital 晨兴资本 and Tiantu Capital

FAQ